e-therapeutics PLC is a United Kingdom-based startup that specializes in computational drug discovery, focusing on developing RNA interference (“RNAi”) therapeutics. The company, founded in 2003, operates in the Biotechnology and Health Care industries, positioning itself at the intersection of technology and medicine. Recently, e-therapeutics PLC secured a significant $13.50M in Post-IPO Equity investment on 30 September 2022, with funding coming from M&G plc. With its slogan "Computing the future of medicine", the company is poised to make significant strides in revolutionizing the healthcare landscape with its innovative approach to drug discovery and therapeutics.
No recent news or press coverage available for e-therapeutics PLC.